We are committed to excellence in patient care, teaching, and research.
We study how the blood system works and how it goes awry to result in disorders such as excessive bleeding, excessive clotting, anemia, leukemia, lymphoma, and myeloma. We work at the cutting edge of molecular and cellular biology, pathophysiology, and applied clinical research.
This work is carried out both as investigator-initiated projects and through collaborative efforts of colleagues at:
- Fred Hutchinson Cancer Research Center
- Fred Hutch/University of Washington Cancer Consortium
- Seattle Cancer Care Alliance
- Bloodworks NW
- Institute for Stem Cell and Regenerative Medicine (ISCRM)
- Basic science departments at the University Washington
- Other Divisions in the Department of Medicine
Funding includes grants National Institute of Health (NIH), other nonprofit organizations, and pharmaceutical companies.
Fellowship and Education
Our fellowship training program prepares physicians for the subspecialty practice of Hematology and Medical Oncology. We focus on training MD and PhD scientists for academic careers as basic, translational, or clinical researchers in the areas of hematopoiesis, hemostasis and thrombosis, transfusion medicine, cytopenias, myeloproliferative disorders, leukemia, lymphoma, myeloma, myelodysplasia, and gene therapy.
Our faculty actively participate in many formal and informal teaching conferences, lecture series, and continuing medical education programs throughout the University of Washington-affiliated system.
Our faculty provide expert primary, secondary, tertiary and consultative care for patients with a diverse spectrum of benign and malignant blood-related disorders.
Sites of practice: The University of Washington Medical Center, Seattle Cancer Care Alliance (a joint practice of the University of Washington, Fred Hutch, and Seattle Children's Hospital), Harborview Medical Center, the Northwest Center for Bleeding Disorders, and the VA Puget Sound Health Care System.